Acute Promyelocytic Leukemia with Hyperleukocytosis: Improving Outcomes with Current Therapy.
作者信息
Vaid Tejasvini, Aggarwal Mukul, Khare Akriti, Viswanathan Ganesh Kumar, Dass Jasmita, Kumar Pradeep, Dhawan Rishi, Seth Tulika, Tyagi Seema, Mahapatra Manoranjan
机构信息
Department of Haematology, All India Institute of Medical Sciences, New Delhi, India.
出版信息
Indian J Hematol Blood Transfus. 2022 Apr;38(2):427-428. doi: 10.1007/s12288-021-01509-7. Epub 2022 Jan 17.
Abstract
摘要
相似文献
1
Acute Promyelocytic Leukemia with Hyperleukocytosis: Improving Outcomes with Current Therapy.伴有白细胞增多症的急性早幼粒细胞白血病：当前治疗改善预后情况
Indian J Hematol Blood Transfus. 2022 Apr;38(2):427-428. doi: 10.1007/s12288-021-01509-7. Epub 2022 Jan 17.
2
The management of hyperleukocytosis in 2017: Do we still need leukapheresis?2017年高白细胞血症的管理：我们仍然需要白细胞去除术吗？
Transfus Apher Sci. 2018 Feb;57(1):4-7. doi: 10.1016/j.transci.2018.02.006. Epub 2018 Feb 20.
3
4
Minimally early morbidity in children with acute myeloid leukemia and hyperleukocytosis treated with prompt chemotherapy without leukapheresis.急性髓系白血病合并高白细胞血症患儿在未进行白细胞单采术的情况下接受快速化疗后的早期轻微发病率。
J Formos Med Assoc. 2014 Nov;113(11):833-8. doi: 10.1016/j.jfma.2014.01.006. Epub 2014 Feb 15.
5
Polymorphisms in arsenic (+ 3 oxidation state) methyltransferase (AS3MT) predict the occurrence of hyperleukocytosis and arsenic metabolism in APL patients treated with AsO.砷 (+3 氧化态) 甲基转移酶 (AS3MT) 中的多态性可预测接受 AsO 治疗的 APL 患者发生高白细胞血症和砷代谢的情况。
Arch Toxicol. 2020 Apr;94(4):1203-1213. doi: 10.1007/s00204-020-02686-6. Epub 2020 Feb 28.
6
Hyperleukocytosis in Childhood Acute Leukemia: Early Complications and Survival Outcomes.儿童急性白血病中的高白细胞血症：早期并发症及生存结局
Cancers (Basel). 2023 Jun 6;15(12):3072. doi: 10.3390/cancers15123072.
7
Characteristics and outcomes of patients with acute promyelocytic leukemia and extreme hyperleukocytosis at presentation.初诊时急性早幼粒细胞白血病伴极度白细胞增多患者的特征及预后
Blood Adv. 2023 Jun 13;7(11):2580-2585. doi: 10.1182/bloodadvances.2022007126.
8
Acute promyelocytic leukemia in pregnancy: all-trans retinoic acid as a newer therapeutic option.妊娠期急性早幼粒细胞白血病：全反式维甲酸作为一种新的治疗选择。
Obstet Gynecol. 1994 May;83(5 Pt 2):808-11.
9
[244 patients with hyperleukocytic acute leukemia. Shanghai Leukemia Cooperation Group].[244例高白细胞急性白血病患者。上海白血病协作组]
Zhonghua Nei Ke Za Zhi. 1997 Aug;36(8):532-5.
10
[Retinoic acid in treating acute promyelocytic leukemia with hyperleukocytosis and its therapeutic strategy].
Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2008 Apr;16(2):439-41.
本文引用的文献
1
High Risk Acute Promyelocytic Leukemia - An Enigma for Hematologists: Optimizing Treatment with APML-4 Protocol.高危急性早幼粒细胞白血病——血液科医生的难题：采用APML-4方案优化治疗
Indian J Hematol Blood Transfus. 2022 Apr;38(2):394-402. doi: 10.1007/s12288-021-01478-x. Epub 2021 Sep 3.
2
Clinical characteristics and outcomes in patients with acute promyelocytic leukaemia and hyperleucocytosis.急性早幼粒细胞白血病合并白细胞增多症患者的临床特征及预后
Br J Haematol. 2015 Mar;168(5):646-53. doi: 10.1111/bjh.13189. Epub 2014 Oct 14.
3
Retinoic acid and arsenic trioxide for acute promyelocytic leukemia.全反式维甲酸和三氧化二砷联合治疗急性早幼粒细胞白血病。
N Engl J Med. 2013 Jul 11;369(2):111-21. doi: 10.1056/NEJMoa1300874.
4
All-trans-retinoic acid, idarubicin, and IV arsenic trioxide as initial therapy in acute promyelocytic leukemia (APML4).全反式维甲酸、去甲氧柔红霉素和静脉注射三氧化二砷作为急性早幼粒细胞白血病（APML4）的初始治疗。
Blood. 2012 Aug 23;120(8):1570-80; quiz 1752. doi: 10.1182/blood-2012-02-410746. Epub 2012 Jun 19.
Zotero 插件